Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rafael Holdings, Inc.

1.44
+0.10007.46%
Post-market: 1.440.0001+0.01%18:00 EDT
Volume:179.15K
Turnover:244.34K
Market Cap:50.53M
PE:-1.56
High:1.44
Open:1.35
Low:1.32
Close:1.34
52wk High:3.19
52wk Low:1.28
Shares:35.09M
Float Shares:15.20M
Volume Ratio:1.14
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9221
EPS(LYR):-1.4491
ROE:-26.78%
ROA:-9.82%
PB:0.63
PE(LYR):-0.99

Loading ...

Cyclo Therapeutics, a Subsidiary of Rafael Holdings, to Present Research on Niemann-Pick Disease at ICIEM 2025

Reuters
·
Aug 27

Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15TH International Congress of Inborn Errors of Metabolism (Iciem)

THOMSON REUTERS
·
Aug 27

Rafael Holdings Inc. Files Initial Statement of Beneficial Ownership for COO Joshua M Fine

Reuters
·
Aug 12

Rafael Holdings Inc. Announces Executive Reshuffle: John Goldberg Resigns, Joshua Fine Appointed as Chief Operating Officer

Reuters
·
Aug 08

Rafael Holdings Inc. Files Initial Statement of Beneficial Ownership; N. Scott Fine Named as Director

Reuters
·
Jul 23

Rafael Holdings Inc. Announces Continuation of Phase 3 TransportNPC Study for Trappsol® Cyclo™ Following Positive Interim Analysis

Reuters
·
Jun 18

Cyclo Therapeutics' Phase 3 NPC1 Study Advances with Positive Interim Data Review

Reuters
·
Jun 18

BUZZ-U.S. STOCKS ON THE MOVE-Vaxart, DoubleVerify, Cracker Barrel

Reuters
·
Jun 12

BRIEF-Rafael Holdings Q3 Net Income USD -4.051 Million

Reuters
·
Jun 11

Rafael Holdings Reports Q3 FY2025 Net Loss of $4.8M, EPS Improves to $0.19 from $1.36 Year-Over-Year

Reuters
·
Jun 11

Press Release: Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

Dow Jones
·
Jun 11

Exec Chairman, CEO & President Howard S. Jonas Acquires Common Shares of Rafael Holdings Inc

Reuters
·
Jun 10

BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Chip Stocks, EchoStar

Reuters
·
Jun 10

Rafael Closes $25 Million Rights Offering

MT Newswires Live
·
Jun 05

Press Release: Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

Dow Jones
·
Jun 05

Protara Therapeutics Names William Conkling as Chief Commercial Officer

MT Newswires Live
·
Jun 03

Press Release: Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol(R) Cyclo(TM)

Dow Jones
·
May 21

Rafael Holdings Inc. Announces New Standby Purchase Agreement with Howard S. Jonas

Reuters
·
May 07

Rafael Holdings CEO Conkling Steps Down; Replaced by Former CEO Jonas

Dow Jones
·
Apr 25